GlassScriptPhysician profile
Charta Klaisri
NPI 1255616116
$2,126.16
in general payments reported to CMS, 2019-2025
12 companies · $54.39 in 2025
The $54.39 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $52.23 · 2021: $1,345 · 2022: $38.31 · 2023: $18.78 · 2024: $415 · 2025: $54.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $1,269.52 | 2020-2025 | |
| Koya Medical, INC. | $363.18 | 2024-2025 | Dayspring, Koya Medical, Koya Medical |
| Zimmer Biomet Holdings, INC. | $133.79 | 2019 | |
| Paratek Pharmaceuticals, INC. | $124.97 | 2021 | |
| Smith+Nephew, INC. | $61.04 | 2019-2024 | Grafix |
| Musculoskeletal Transplant Foundation INC. | $36.23 | 2022-2023 | |
| Orpyx Medical Technologies US INC. | $31.94 | 2024 | Orpyx Si |
| Bioventus LLC | $28.26 | 2019 | |
| Biotissue Holdings INC. | $22.70 | 2024 | |
| Wright Medical Technology, INC. | $22.24 | 2020 | |
| Tactile Systems Technology INC | $20.48 | 2019 | |
| Advanced Oxygen Therapy INC. | $11.81 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charta Klaisri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.